Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

More than half of those who died were over the age of 65. There was a second, much smaller outbreak of SARS in 2004, linked to a medical lab in China. It probably occurred as a result of direct ...

Conditions like autism or Asperger’s syndrome qualify if they meet Sars’s standard for "moderate to severe" limitation.

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

But Harvard Medical School’s Haytham Kaafarani ... many symptoms that showed up.” Now, with SARS-CoV-2 having infected more than 100 million people and counting, it’s clear that the virus can indeed ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2 ... plays a dual role in a wide range of medical applications owing to its neuroprotective ...

Get Instant Summarized Text (Gist) A new method, Deep Novel Mutation Search (DNMS), uses AI to predict potential mutations in the SARS-CoV-2 spike protein. By employing a fine-tuned language model ...

“The SARS-CoV-2 virus also continues to mutate ... The research is supported by the Medical Research Future Fund, the Wellcome Trust and generous philanthropic donations for COVID research and ...

COVID-19 in children and adolescents is associated with adverse long-term kidney outcomes, such as chronic kidney disease (CKD).